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Conclusion: This experiment revealed a small subpopulation
of cells that remain alive irrespective of concentration of antimi-
crobial agents. In exponential phase the number of persister cell
was low than stationary growth phase populations. In addition, the
persister cells of P. aeruginosa exhibit a high tolerance to the vari-
ety of antibiotics, and phenotype was not inherited as tested with
four passages of P. aeruginosapopulations. In-silico results show the
presence of parDE, relBE, and higBA toxin-antitoxin systems among
which ParE toxin generates double strand breaks while RelE & HigB
toxins induce mRNA cleavage.
http://dx.doi.org/10.1016/j.ijid.2016.02.609
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Background: Antimicrobial stewardship programs (ASP) in col-
laboration with infection control have been shown to reduce rates
of hospital-acquired infections (HAI) and prevent development of
resistant organisms. ASP ensures the medical staff is appropriately
educated on protocols developed by infection control and moni-
tors the use of antibiotics to reduce the risk of C. difﬁcile and other
multi-drug- resistant organisms. These services are imperative in
hematology/oncology patients who are at elevated risk for acquir-
ing HAIs due to immunosuppression, chronic intravenous access,
and frequent hospitalizations. We sought to determine if ASP in
combination with infection control could reduce HAIs in a subspe-
cialty oncology hospital.
Methods & Materials: We performed a retrospective review of
HAIs between January 2012 and September 2015. Antimicrobial
usage from July 2011 through September 2015 and antimicrobial
susceptibility data from December 2010 through November 2014
was collected. During this time, ASP and infection control strategies
included: nursing education on appropriate methods of accessing
ports andmanagement of foley catheters, adherence to strict hand-
hygiene protocols, consultation by the infectious disease physician,
anddaily reviewof all patients on antimicrobial agents by the infec-
tious disease pharmacist.
Results: In a 74-bed subspecialty cancer treatment facility
with oncology and stem cell transplant patients, ASP was estab-
lished in 2012. Since inception, the rate of central line-associated
blood stream infections (CLABSI) steadily declined and was main-
tained below the national pooled mean since May 2013 (Figure 1).
Additionally, no incidences of CLABSIs were reported for 1 year
(January 2014 through February 2015). Due to the low usage of
meropenem and imipenem (24 and 29 days of therapy per 1,000
patient days respectively) between August 2011 and September
2015, there have been only 3.2 isolates per 1,000 patient days
identiﬁed of Carbapenem-resistant Enterobacteriaceae. Additionally,
rates of HAIMRSA and C. difﬁcile remained extremely low (0.18 and
0.2 infections per 1,000 patient days, respectively) after ASP was
implemented.
Conclusion: Through education, implementation of speciﬁc
protocols, and ASP interventions, the risk of hospitalized hematol-
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ogy/oncology patients acquiring HAI infections and antimicrobial
resistance has been signiﬁcantly reduced. This intervention affords
this high risk population the opportunity to pursue cancer-speciﬁc
treatment with a reduced risk of developing infectious complica-
tions.
http://dx.doi.org/10.1016/j.ijid.2016.02.610
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Background: The interaction of nanoparticles with microor-
ganisms is an emerging ﬁeld. Within this, an area that has been
limitedly explored is the interaction of nanoparticles with viruses.
Recently studies on silver nanoparticles (AgNPs) showed potent
antiviral activity against HIV, HBV, inﬂuenza and dengue virus.
However, synthesis of metallic nanoparticles involves physical and
chemical approach utilizing toxic chemicals, which may hinder its
application for human use. Therefore, development of novel eco-
friendly nanoparticles is of great interest. In the present study, we
synthesizedgreenAgNPswith catechinas reducingagent. Catechin,
a polyphenol being itself having antiviral propertymayenhance the
efﬁciency of AgNPs. We evaluated biogenic catechin AgNPs against
Japanese encephalitis virus (JEV), which is a major public health
problem particularly in Asia.
Methods&Materials:Greennanoparticleswere synthesizedby
addingpuriﬁed catechin intoAgNO3solutionby following standard
method. Standard circulating JEV strain JERG07 (Source: Human,
2007, Assam, India)was used. In vitro assayswere done usingVERO
cell line. Cell viability assay for 2 fold diluted greenAgNPswas done
using MTT standard protocol assay. Cytopathetic effect (CPE) inhi-
bition assaywas performedwith 1Multiplicity of infection (MOI) of
JEV. Cells were also observed daily under inverted microscope and
were assigned a score based on appearance of CPE. Further, virus
yield reduction assay was done to quantify the level of protection
of nanoparticles treated both at pre & post JEV infection.
Results: Transmission Electron Microscopy (TEM) analysis
revealed formationofbiogenicAgNPswithin the sizeof50nm.Max-
imum (100%) cell viability for green nanoparticles was observed in
the range from0.04g/ml to5.85g/ml.Within the samerangeCPE
inhibition assay also showed full protection against JEV. Further,
virus yeild reduction assay showed reduction in plaques number in
comparison to virus control in both pre & post JEV infection cells.
Conclusion: The present studydemonstrated the ability of cate-
chin reduced biogenic AgNPs to prevent JEV infection by inhibition
ofvirusattachmentandpost infectionspread. Future studies should
be focused on elucidating the mechanism of nanoparticle-virus
interaction at cellular and microscopic level.
http://dx.doi.org/10.1016/j.ijid.2016.02.611
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Background: The anterior nares have been shown to be the
main reservoir of Staphylococcus aureus in both children and
adults. The Staphylococcus aureus is transmitted to nares by con-
taminatedhandsand fromsurfaceswhere it can survive formonths.
Colonized health care worker acts as a reservoir for the spread
of Staphylococcus aureus to uncolonized susceptible patients. The
study aims to investigate the nasal carriage of Staphylococcus
aureus among health care workers.
Methods &Materials: A total of 192 nasal swabswere obtained
from health care workers (nursing staff, attendants, and laboratory
personnel) and cultured for carriage of Staphylococcus aureus. Iso-
lates were identiﬁed based on their growth on mannitol salt agar,
blood agar, gram staining, catalase and tube coagulase tests. All the
isolates were subjected to in vitro antibiotic susceptibility testing
as per CLSI guidelines.
Results: Among 192 health care workers, 28 (14.58%) were
Staphylococcus aureus carriers. Highest rate of Staphylococcus
aureus carriage was seen among central clinical laboratory staff
(30.77%) followed this in orthopaedic ward (23.08%). Among 28
Staphylococcus aureus isolates 4(2.08%) were MRSA, 1(0.52%)
inducible clindamycin resistant, 1(0.52%) low levelmupirocin resis-
tant. None of the isolate had constitutive clindamycin resistance
and high level mupirocin resistance. The isolates were sensitive
to Vancomycin (100%), Rifampicin (100%), Clindamycin (96.43%),
Erythromycin (75%), ciproﬂoxacin (71.43%), Cotrimixazole (50%),
Penicillin (0%).
Conclusion: It is important to develop proper protocol for erad-
ication of nasal carriage and strict hospital infection control policy
to reduce carriage of Staphylococcus aureus among health care
workers.
http://dx.doi.org/10.1016/j.ijid.2016.02.612
